Treatment of fibrotic interstitial lung disease: current approaches and future directions
Kerri A. Johannson, Nazia Chaudhuri, Ayodeji Adegunsoye, Paul J. Wolters
Abstract
Fibrotic interstitial lung disease (ILD) represents a large group of pulmonary disorders that are often progressive and associated with high morbidity and early mortality. Important advancements in the past 10 years have enabled a better understanding, characterisation, and treatment of these diseases. This Series paper summarises the current approach to treatment of fibrotic ILDs, both pharmacological and non-pharmacological, including recent discoveries and practice-changing clinical trials. We further outline controversies and challenges, with discussion of evolving concepts and future research directions.
Topics & Concepts
Interstitial lung diseaseMedicineIntensive care medicineIdiopathic pulmonary fibrosisLung diseaseDiseaseLungClinical trialPathologyInternal medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchSystemic Sclerosis and Related Diseases